Chemical Name: 2-[(1R,5S)-3-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hexan-6-yl]acetic acid
Ketohexokinase inhibitor
Molekulargewicht:
356.35
Reinheit:
>98% by HPLC, NMR (conforms)
Formulierung:
White solid
CAS Nummer:
[2102501-84-6]
Formel:
C16H19F3N4O2
Anwendungsbeschreibung:
PF-06835919 is a potent (IC50 = 10 nM KHK-C, 170 nM KHK-A) inhibitor of ketohexokinase (KHK), the first enzyme in the fructose metabolic cascade.1 It displayed high selectivity against other sugar kinases. PF-06835919 prevented hyperinsulinemia, hypertriglyceridemia, and hepatic steatosis in fructose-fed rats.2 The increased tumor proliferation effect of fructose in CaSki cells was inhibited by PF-06835919.3 An interesting new tool to study metabolic and fatty liver diseases.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten